Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific Coast

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 2 S, 2011, Pages 71-77

  Arévalo Herrera, Myriam ^a   Solarte, Yezid ^a   Rocha, Leonardo ^b   Álvarez, Diego ^b   Beier, John C ^c   Herrera, Sócrates ^a,b  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b Malaria Vaccine and Drug Development Center   (Colombia)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUFFY BINDING PROTEIN; ANTISERUM; BLOCKING ANTIBODY; COMPLEMENT; PROTOZOON ANTIBODY;

ADULT; ANOPHELES; ANOPHELES ALBIMANUS; ANTIBODY DETECTION; ARTICLE; COLOMBIA; DISEASE TRANSMISSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PARASITE DEVELOPMENT; PARASITE ISOLATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; ANIMAL; BLOOD; BLOOD GROUP DUFFY SYSTEM; DOSE RESPONSE; IMMUNOLOGY; PARASITOLOGY;

ANOPHELES ALBIMANUS; PLASMODIUM VIVAX;

ANIMALS; ANOPHELES; ANTIBODIES, BLOCKING; ANTIBODIES, PROTOZOAN; COLOMBIA; COMPLEMENT SYSTEM PROTEINS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DUFFY BLOOD-GROUP SYSTEM; FEMALE; HUMANS; IMMUNE SERA; MALARIA, VIVAX; PLASMODIUM VIVAX;

EID: 79952482960     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0085     Document Type: Article

References (31)

1. Doolan DL, Dobano C, Baird JK, 2009. Acquired immunity to malaria. Clin Microbiol Rev 22: 13-36.
2. Baird JK, 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today 11: 105-111.
3. Hviid L, 2005. Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop 95: 270-275. (Pubitemid 41207292)
4. Targett GA, Greenwood BM, 2008. Malaria vaccines and their potential role in the elimination of malaria. Malar J 7 (Suppl 1): S10.
5. Sauerwein RW, 2007. Malaria transmission-blocking vaccines: the bonus of effective malaria control. Microbes Infect 9: 792-795. (Pubitemid 46660681)
6. Munesinghe YD, Mendis KN, Carter R, 1986. Anti-gamete antibodies block transmission of human vivax malaria to mosquitoes. Parasite Immunol 8: 231-238. (Pubitemid 16098750)
7. Healer J, McGuinness D, Hopcroft P, Haley S, Carter R, Riley E, 1997. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infect Immun 65: 3017-3023. (Pubitemid 27342372)
8. Naotunne TS, Karunaweera ND, Del Giudice G, Kularatne MU, Grau GE, Carter R, Mendis KN, 1991. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. J Exp Med 173: 523-529.
9. Bousema JT, Drakeley CJ, Sauerwein RW, 2006. Sexual-stage antibody responses to P. falciparum in endemic populations. Curr Mol Med 6: 223-229.
10. Mendis KN, Munesinghe YD, de Silva YN, Keragalla I, Carter R, 1987. Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infect Immun 55: 369-372. (Pubitemid 17004114)
11. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM, 2007. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 77: 79-87.
12. Gamage-Mendis AC, Rajakaruna J, Carter R, Mendis KN, 1992. Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka. Parasite Immunol 14: 385-396.
13. Ranawaka MB, Munesinghe YD, de Silva DM, Carter R, Mendis KN, 1988. Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection. Infect Immun 56: 1820-1824.
14. Arévalo-Herrera M, Solarte Y, Zamora F, Mendez F, Yasnot MF, Rocha L, Long C, Miller LH, Herrera S, 2005. Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia. Am J Trop Med Hyg 73: 38-43. (Pubitemid 41688447)
15. Ramsey JM, Salinas E, Rodriguez MH, 1996. Acquired transmission-blocking immunity to Plasmodium vivax in a population of southern coastal Mexico. Am J Trop Med Hyg 54: 458-463. (Pubitemid 26162238)
16. Touray MG, Seeley DC Jr, Miller LH, 1994. Plasmodium gallinaceum : differential lysis of two developmental stages of malaria sporozoites by the alternative pathway of complement. Exp Parasitol 78: 294-301. (Pubitemid 24171667)
17. Read D, Lensen AH, Begarnie S, Haley S, Raza A, Carter R, 1994. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing. Parasite Immunol 16: 511-519. (Pubitemid 24355238)
18. Roeffen W, Geeraedts F, Eling W, Beckers P, Wizel B, Kumar N, Lensen T, Sauerwein R, 1995. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent. Infect Immun 63: 467-471.
19. Scholz SM, Simon N, Lavazec C, Dude MA, Templeton TJ, Pradel G, 2008. PfCCp proteins of Plasmodium falciparum: gametocyte-specific expression and role in complement-mediated inhibition of exflagellation. Int J Parasitol 38: 327-340. (Pubitemid 351215431)
20. Siddique ME, Ahmed S, 1995. Serum complement C4 levels during acute malarial infection and post-treatment period. Indian J Pathol Microbiol 38: 335-339.
21. Shute GT, 1988. The microscopic diagnosis of malaria. Wernsdorfer H, McGregor IA, eds. Principles and Practice of Malariology. London: Longman Group UK Limited, 781-814.
22. Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y, 1995. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 95: 407-410.
23. Hurtado S, Salas ML, Romero JF, Zapata JC, Ortiz H, Arévalo- Herrera M, Herrera S, 1997. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratorybred Anopheles albimanus. Ann Trop Med Parasitol 91: 49-60. (Pubitemid 27081179)
24. Eyles DE, 1950. A stain for malarial oocysts in temporary preparations. J Parasitol 36: 501.
25. Lensen A, van Druten J, Bolmer M, van Gemert G, Eling W, Sauerwein R, 1996. Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera. Trans R Soc Trop Med Hyg 90: 20-22. (Pubitemid 26069437)
26. Boudin C, Diop A, Gaye A, Gadiaga L, Gouagna C, Safeukui I, Bonnet S, 2005. Plasmodium falciparum transmission blocking immunity in three areas with perennial or seasonal endemicity and different levels of transmission. Am J Trop Med Hyg 73: 1090-1095. (Pubitemid 43038260)
27. Peiris JS, Premawansa S, Ranawaka MB, Udagama PV, Munasinghe YD, Nanayakkara MV, Gamage CP, Carter R, David PH, Mendis KN, 1988. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. Am J Trop Med Hyg 39: 26-32.
28. Naotunne TD, Rathnayake KD, Jayasinghe A, Carter R, Mendis KN, 1990. Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica. Exp Parasitol 71: 305-313. (Pubitemid 20340954)
29. Karunaweera ND, Carter R, Grau GE, Kwiatkowski D, Del Giudice G, Mendis KN, 1992. Tumour necrosis factor-dependent parasite-killing effects during paroxysms in non-immune Plasmodium vivax malaria patients. Clin Exp Immunol 88: 499-505.
30. Karunaweera ND, Wijesekera SK, Wanasekera D, Mendis KN, Carter R, 2003. The paroxysm of Plasmodium vivax malaria. Trends Parasitol 19: 188-193. (Pubitemid 36416607)
31. Premawansa S, Peiris JS, Perera KL, Ariyaratne G, Carter R, Mendis KN, 1990. Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates. J Immunol 144: 4376-4383. (Pubitemid 20187783)